Frec Markets Inc’s Biogen BIIB Stock Holding History

Frec Markets Inc’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$898K	Buy	4,158 +1,530	+58%	+$293K	0.08%	282
2026 Q1	$482K	Buy	2,628 +474	+22%	+$87.3K	0.08%	266
2025 Q4	$379K	Buy	+2,154	New	+$352K	0.11%	180

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Frec Markets Inc's BIIB Position: Q2 2026 in Review

Frec Markets Inc increased its Biogen (BIIB) stake by 58% in Q2 2026, buying an estimated $293K and bringing the position to 4,158 shares worth $898K. The position accounts for 0.08% of the portfolio, ranked #282.

Frec Markets Inc first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Frec Markets Inc held 4,158 shares of Biogen worth $898K as of Q2 2026.
Frec Markets Inc bought 1,530 Biogen shares in Q2 2026, an estimated $293K.
Biogen made up 0.08% of Frec Markets Inc's portfolio in Q2 2026, its #282 holding.
Frec Markets Inc first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.